

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | blood coagulation, intrinsic pathway (GO:0007597) | 5.11459840 |
| 2 | thrombin receptor signaling pathway (GO:0070493) | 4.36217735 |
| 3 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.22726038 |
| 4 | hormone catabolic process (GO:0042447) | 4.19787736 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 4.00685550 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 4.00685550 |
| 7 | negative regulation of norepinephrine secretion (GO:0010700) | 4.00063261 |
| 8 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.91098025 |
| 9 | mesodermal cell differentiation (GO:0048333) | 3.76824155 |
| 10 | surfactant homeostasis (GO:0043129) | 3.76238857 |
| 11 | glomerular basement membrane development (GO:0032836) | 3.69227792 |
| 12 | platelet degranulation (GO:0002576) | 3.67368248 |
| 13 | epithelial cell-cell adhesion (GO:0090136) | 3.66779555 |
| 14 | polyketide metabolic process (GO:0030638) | 3.61701052 |
| 15 | doxorubicin metabolic process (GO:0044598) | 3.61701052 |
| 16 | daunorubicin metabolic process (GO:0044597) | 3.61701052 |
| 17 | protein carboxylation (GO:0018214) | 3.60937122 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.60937122 |
| 19 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.53742768 |
| 20 | negative regulation of protein localization to cell surface (GO:2000009) | 3.52496437 |
| 21 | cell-substrate junction assembly (GO:0007044) | 3.51091820 |
| 22 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.49900590 |
| 23 | low-density lipoprotein particle remodeling (GO:0034374) | 3.42661566 |
| 24 | regulation of lipoprotein metabolic process (GO:0050746) | 3.42275449 |
| 25 | glomerulus development (GO:0032835) | 3.30846672 |
| 26 | positive regulation of hemostasis (GO:1900048) | 3.29824533 |
| 27 | positive regulation of blood coagulation (GO:0030194) | 3.29824533 |
| 28 | platelet aggregation (GO:0070527) | 3.24937295 |
| 29 | notochord development (GO:0030903) | 3.21472561 |
| 30 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.20844841 |
| 31 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.20656379 |
| 32 | hypotonic response (GO:0006971) | 3.20400050 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.19578688 |
| 34 | L-phenylalanine metabolic process (GO:0006558) | 3.19578688 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.16457460 |
| 36 | metanephric mesenchyme development (GO:0072075) | 3.15532977 |
| 37 | desmosome organization (GO:0002934) | 3.15462471 |
| 38 | peptide catabolic process (GO:0043171) | 3.13422444 |
| 39 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.11894786 |
| 40 | kidney mesenchyme development (GO:0072074) | 3.10249073 |
| 41 | negative regulation of platelet activation (GO:0010544) | 3.09342303 |
| 42 | L-phenylalanine catabolic process (GO:0006559) | 3.08000614 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.08000614 |
| 44 | angiogenesis involved in wound healing (GO:0060055) | 3.04911848 |
| 45 | positive regulation of coagulation (GO:0050820) | 3.03065966 |
| 46 | positive regulation of histone deacetylation (GO:0031065) | 3.01911325 |
| 47 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.00333074 |
| 48 | chemical homeostasis within a tissue (GO:0048875) | 2.99908420 |
| 49 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.98343199 |
| 50 | keratan sulfate catabolic process (GO:0042340) | 2.97633688 |
| 51 | lung vasculature development (GO:0060426) | 2.97587558 |
| 52 | induction of positive chemotaxis (GO:0050930) | 2.96290040 |
| 53 | establishment of skin barrier (GO:0061436) | 2.94337463 |
| 54 | type B pancreatic cell development (GO:0003323) | 2.92111197 |
| 55 | regulation of integrin activation (GO:0033623) | 2.91551862 |
| 56 | protein retention in ER lumen (GO:0006621) | 2.91061568 |
| 57 | fibrinolysis (GO:0042730) | 2.90669122 |
| 58 | nephron epithelium morphogenesis (GO:0072088) | 2.86536740 |
| 59 | nephron tubule morphogenesis (GO:0072078) | 2.86536740 |
| 60 | basement membrane organization (GO:0071711) | 2.86269618 |
| 61 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.85685898 |
| 62 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.84474568 |
| 63 | toxin metabolic process (GO:0009404) | 2.82531463 |
| 64 | exocrine pancreas development (GO:0031017) | 2.81798404 |
| 65 | hippo signaling (GO:0035329) | 2.81696008 |
| 66 | negative regulation of blood coagulation (GO:0030195) | 2.80962607 |
| 67 | negative regulation of hemostasis (GO:1900047) | 2.80962607 |
| 68 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.80842123 |
| 69 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.80842123 |
| 70 | endothelium development (GO:0003158) | 2.80527718 |
| 71 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.78073473 |
| 72 | regulation of water loss via skin (GO:0033561) | 2.77344126 |
| 73 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.76461289 |
| 74 | positive regulation of receptor recycling (GO:0001921) | 2.75320189 |
| 75 | negative regulation of phagocytosis (GO:0050765) | 2.75084786 |
| 76 | regulation of early endosome to late endosome transport (GO:2000641) | 2.75060983 |
| 77 | negative regulation of catenin import into nucleus (GO:0035414) | 2.73355653 |
| 78 | endocardial cushion development (GO:0003197) | 2.72868156 |
| 79 | response to dietary excess (GO:0002021) | 2.71893981 |
| 80 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.71454787 |
| 81 | extracellular fibril organization (GO:0043206) | 2.70997884 |
| 82 | white fat cell differentiation (GO:0050872) | 2.70718300 |
| 83 | adherens junction assembly (GO:0034333) | 2.68404854 |
| 84 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.67213739 |
| 85 | cellular response to vitamin (GO:0071295) | 2.66961156 |
| 86 | negative regulation of coagulation (GO:0050819) | 2.64507947 |
| 87 | glandular epithelial cell development (GO:0002068) | 2.63479964 |
| 88 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.59068913 |
| 89 | glomerular visceral epithelial cell development (GO:0072015) | 2.58771301 |
| 90 | peptide hormone processing (GO:0016486) | 2.58216095 |
| 91 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.58098542 |
| 92 | cellular response to vitamin D (GO:0071305) | 2.57727290 |
| 93 | beta-amyloid metabolic process (GO:0050435) | 2.56925280 |
| 94 | positive regulation of wound healing (GO:0090303) | 2.56286314 |
| 95 | dorsal/ventral axis specification (GO:0009950) | 2.55986395 |
| 96 | renal tubule morphogenesis (GO:0061333) | 2.55685439 |
| 97 | cell proliferation involved in metanephros development (GO:0072203) | 2.55625094 |
| 98 | regulation of protein localization to cell surface (GO:2000008) | 2.54886018 |
| 99 | hemidesmosome assembly (GO:0031581) | 2.54187826 |
| 100 | regulation of glomerulus development (GO:0090192) | 2.54051689 |
| 101 | negative regulation of wound healing (GO:0061045) | 2.53828226 |
| 102 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.53770972 |
| 103 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.52698101 |
| 104 | cell proliferation involved in kidney development (GO:0072111) | 2.52377302 |
| 105 | cell-substrate adherens junction assembly (GO:0007045) | 2.52166499 |
| 106 | focal adhesion assembly (GO:0048041) | 2.52166499 |
| 107 | regulation of platelet aggregation (GO:0090330) | 2.50252131 |
| 108 | regulation of platelet activation (GO:0010543) | 2.49991074 |
| 109 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.49908726 |
| 110 | lymph vessel development (GO:0001945) | 2.48291618 |
| 111 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.48263411 |
| 112 | gap junction assembly (GO:0016264) | 2.48123018 |
| 113 | regulation of catenin import into nucleus (GO:0035412) | 2.47927939 |
| 114 | regulation of cardioblast proliferation (GO:0003264) | 2.47627844 |
| 115 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.47627844 |
| 116 | regulation of apoptotic cell clearance (GO:2000425) | 2.46634342 |
| 117 | cyclooxygenase pathway (GO:0019371) | 2.46484124 |
| 118 | cell-matrix adhesion (GO:0007160) | 2.46244987 |
| 119 | regulation of complement activation (GO:0030449) | 2.45518808 |
| 120 | negative regulation of stem cell proliferation (GO:2000647) | 2.45316998 |
| 121 | negative regulation of focal adhesion assembly (GO:0051895) | 2.44583605 |
| 122 | negative regulation of cell junction assembly (GO:1901889) | 2.44583605 |
| 123 | negative regulation of adherens junction organization (GO:1903392) | 2.44583605 |
| 124 | regulation of hemostasis (GO:1900046) | 2.44343184 |
| 125 | regulation of blood coagulation (GO:0030193) | 2.44343184 |
| 126 | mesenchymal cell differentiation (GO:0048762) | 2.44165271 |
| 127 | gland morphogenesis (GO:0022612) | 2.43820798 |
| 128 | positive regulation of adherens junction organization (GO:1903393) | 2.43483713 |
| 129 | positive regulation of cell junction assembly (GO:1901890) | 2.42913883 |
| 130 | positive regulation of focal adhesion assembly (GO:0051894) | 2.42913883 |
| 131 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.42801452 |
| 132 | cellular response to prostaglandin stimulus (GO:0071379) | 2.42195295 |
| 133 | multicellular organismal water homeostasis (GO:0050891) | 2.42010402 |
| 134 | positive regulation of p38MAPK cascade (GO:1900745) | 2.41518093 |
| 135 | cell differentiation involved in metanephros development (GO:0072202) | 2.40893788 |
| 136 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.40095494 |
| 137 | regulation of endothelial cell differentiation (GO:0045601) | 2.39877029 |
| 138 | apoptotic cell clearance (GO:0043277) | 2.39724546 |
| 139 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.39654682 |
| 140 | regulation of protein activation cascade (GO:2000257) | 2.39491243 |
| 141 | valine metabolic process (GO:0006573) | 2.39134237 |
| 142 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.38673389 |
| 143 | negative regulation of cartilage development (GO:0061037) | 2.38536265 |
| 144 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.38400020 |
| 145 | muscle cell migration (GO:0014812) | 2.38336138 |
| 146 | bone trabecula formation (GO:0060346) | 2.38166799 |
| 147 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.38165690 |
| 148 | endocardial cushion morphogenesis (GO:0003203) | 2.38153110 |
| 149 | outer ear morphogenesis (GO:0042473) | 2.37514159 |
| 150 | protein localization to cell surface (GO:0034394) | 2.37267529 |
| 151 | receptor recycling (GO:0001881) | 2.36705309 |
| 152 | cardiac muscle cell proliferation (GO:0060038) | 2.36479782 |
| 153 | keratinocyte proliferation (GO:0043616) | 2.36071676 |
| 154 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.35649441 |
| 155 | positive regulation of catenin import into nucleus (GO:0035413) | 2.34859803 |
| 156 | mesenchymal to epithelial transition (GO:0060231) | 2.33917207 |
| 157 | inner ear receptor cell development (GO:0060119) | 2.33520972 |
| 158 | cell junction assembly (GO:0034329) | 2.33520396 |
| 159 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.33236712 |
| 160 | negative regulation of epidermis development (GO:0045683) | 2.33207557 |
| 161 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.32820070 |
| 162 | platelet activation (GO:0030168) | 2.31494073 |
| 163 | regulation of positive chemotaxis (GO:0050926) | 2.31393677 |
| 164 | regulation of norepinephrine secretion (GO:0014061) | 2.31069149 |
| 165 | positive regulation of positive chemotaxis (GO:0050927) | 2.30898585 |
| 166 | regulation of coagulation (GO:0050818) | 2.30633049 |
| 167 | COPII vesicle coating (GO:0048208) | 2.29994038 |
| 168 | mesonephric tubule development (GO:0072164) | 2.29653887 |
| 169 | glandular epithelial cell differentiation (GO:0002067) | 2.29426509 |
| 170 | mesonephric epithelium development (GO:0072163) | 2.29173818 |
| 171 | positive regulation of chondrocyte differentiation (GO:0032332) | 2.29004866 |
| 172 | paraxial mesoderm development (GO:0048339) | 2.28774768 |
| 173 | mammary gland development (GO:0030879) | 2.28747232 |
| 174 | high-density lipoprotein particle remodeling (GO:0034375) | 2.28555942 |
| 175 | brown fat cell differentiation (GO:0050873) | 2.28155838 |
| 176 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.28104602 |
| 177 | positive regulation of osteoblast proliferation (GO:0033690) | 2.27944412 |
| 178 | regulation of protein localization to plasma membrane (GO:1903076) | 2.26923350 |
| 179 | negative regulation of catecholamine secretion (GO:0033604) | 2.25824796 |
| 180 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.25782399 |
| 181 | glomerular epithelial cell development (GO:0072310) | 2.24752779 |
| 182 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.24206026 |
| 183 | collagen fibril organization (GO:0030199) | 2.23693909 |
| 184 | cell-cell junction assembly (GO:0007043) | 2.23462831 |
| 185 | mesenchyme morphogenesis (GO:0072132) | 2.23015972 |
| 186 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.23007746 |
| 187 | metanephros development (GO:0001656) | 2.22805004 |
| 188 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.22488068 |
| 189 | positive regulation of protein deacetylation (GO:0090312) | 2.22299966 |
| 190 | positive regulation of glomerulus development (GO:0090193) | 2.22092157 |
| 191 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.21920348 |
| 192 | stress fiber assembly (GO:0043149) | 2.21648366 |
| 193 | ureteric bud development (GO:0001657) | 2.21554128 |
| 194 | protein heterotrimerization (GO:0070208) | 2.21013478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.01617493 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.92717766 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.24711049 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.20802446 |
| 5 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.02970009 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.71135487 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.64430156 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.55906856 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.55133831 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.40789709 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.40514003 |
| 12 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.29405232 |
| 13 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.29405232 |
| 14 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.29405232 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28345064 |
| 16 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.19006420 |
| 17 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.18877251 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.17511899 |
| 19 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.12962268 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.11910289 |
| 21 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.10842099 |
| 22 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.96742068 |
| 23 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94742515 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.91911707 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.91127623 |
| 26 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.86454344 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86192145 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.85056309 |
| 29 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.82480545 |
| 30 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.81138656 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72327682 |
| 32 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.67532155 |
| 33 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.65885706 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.63808018 |
| 35 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.60739494 |
| 36 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.60181772 |
| 37 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.59430038 |
| 38 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.59207321 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58905105 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.57617710 |
| 41 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.56390167 |
| 42 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55985441 |
| 43 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55985441 |
| 44 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.52315065 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.51850221 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51674988 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50617721 |
| 48 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.50551095 |
| 49 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.45884396 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45700511 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.44809650 |
| 52 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.44144675 |
| 53 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.43994835 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.43765221 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42986039 |
| 56 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.42204156 |
| 57 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.42204156 |
| 58 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.39336933 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.38788529 |
| 60 | GATA2_19941826_ChIP-Seq_K562_Human | 1.38727407 |
| 61 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.38369931 |
| 62 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.37885532 |
| 63 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.36144782 |
| 64 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35533028 |
| 65 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.34408938 |
| 66 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34314996 |
| 67 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.33473261 |
| 68 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.33437232 |
| 69 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.31948358 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31907906 |
| 71 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30825509 |
| 72 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.26501156 |
| 73 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.26418740 |
| 74 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.26251341 |
| 75 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.24692444 |
| 76 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24658282 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.23724174 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23524203 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23524203 |
| 80 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.23282016 |
| 81 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23246885 |
| 82 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22874420 |
| 83 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22747838 |
| 84 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21478941 |
| 85 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20307801 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19673624 |
| 87 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18310555 |
| 88 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.18193447 |
| 89 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17247696 |
| 90 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.16977648 |
| 91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16059455 |
| 92 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15343818 |
| 93 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.14509837 |
| 94 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13808502 |
| 95 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11718071 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11510295 |
| 97 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.11270218 |
| 98 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10137878 |
| 99 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.09533291 |
| 100 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09497075 |
| 101 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09289746 |
| 102 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09289746 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08894023 |
| 104 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.08851731 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08343213 |
| 106 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.08005830 |
| 107 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.07395177 |
| 108 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06364677 |
| 109 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.06096583 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06072113 |
| 111 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04724305 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04487840 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04106016 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03912522 |
| 115 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03815067 |
| 116 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.02911987 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02782557 |
| 118 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02730513 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02621641 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02293726 |
| 121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01837891 |
| 122 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.01537315 |
| 123 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01391128 |
| 124 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01186241 |
| 125 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01033191 |
| 126 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00363201 |
| 127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99973559 |
| 128 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99873612 |
| 129 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.99829705 |
| 130 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98619440 |
| 131 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95996239 |
| 132 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.95509068 |
| 133 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.95505069 |
| 134 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.95204902 |
| 135 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94987382 |
| 136 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94275100 |
| 137 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93941534 |
| 138 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93890435 |
| 139 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.93747788 |
| 140 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.93243733 |
| 141 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.92492751 |
| 142 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.91380264 |
| 143 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.90890383 |
| 144 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.90457007 |
| 145 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89662348 |
| 146 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88434330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 4.16719697 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 3.60255386 |
| 3 | MP0008004_abnormal_stomach_pH | 3.45669752 |
| 4 | MP0004272_abnormal_basement_membrane | 3.10182645 |
| 5 | MP0002254_reproductive_system_inflammat | 3.06401578 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 2.91887375 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.81915863 |
| 8 | MP0005409_darkened_coat_color | 2.62334030 |
| 9 | MP0005670_abnormal_white_adipose | 2.59224687 |
| 10 | MP0000678_abnormal_parathyroid_gland | 2.58752718 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.51025891 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.48354001 |
| 13 | MP0005275_abnormal_skin_tensile | 2.40913970 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.39048044 |
| 15 | MP0004043_abnormal_pH_regulation | 2.34823158 |
| 16 | MP0003122_maternal_imprinting | 2.23942139 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.16021666 |
| 18 | MP0010030_abnormal_orbit_morphology | 2.00464947 |
| 19 | MP0003283_abnormal_digestive_organ | 1.98736831 |
| 20 | MP0004084_abnormal_cardiac_muscle | 1.96927752 |
| 21 | MP0000003_abnormal_adipose_tissue | 1.95172257 |
| 22 | MP0008961_abnormal_basal_metabolism | 1.94158164 |
| 23 | MP0000579_abnormal_nail_morphology | 1.87943630 |
| 24 | MP0009379_abnormal_foot_pigmentation | 1.85394391 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.81706328 |
| 26 | MP0003123_paternal_imprinting | 1.81289843 |
| 27 | MP0001879_abnormal_lymphatic_vessel | 1.79391236 |
| 28 | MP0003950_abnormal_plasma_membrane | 1.78657022 |
| 29 | MP0005501_abnormal_skin_physiology | 1.73025966 |
| 30 | MP0005503_abnormal_tendon_morphology | 1.71057266 |
| 31 | MP0002796_impaired_skin_barrier | 1.68227637 |
| 32 | MP0001270_distended_abdomen | 1.68101839 |
| 33 | MP0003942_abnormal_urinary_system | 1.66283470 |
| 34 | MP0006054_spinal_hemorrhage | 1.65081915 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.62221692 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.59738427 |
| 37 | MP0001958_emphysema | 1.57955227 |
| 38 | MP0000534_abnormal_ureter_morphology | 1.56508571 |
| 39 | MP0002060_abnormal_skin_morphology | 1.56356210 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.56228034 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.55747279 |
| 42 | MP0005248_abnormal_Harderian_gland | 1.54411449 |
| 43 | MP0000163_abnormal_cartilage_morphology | 1.53227213 |
| 44 | MP0005360_urolithiasis | 1.51609336 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.50442708 |
| 46 | MP0009250_abnormal_appendicular_skeleto | 1.49200498 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.47920803 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.47212409 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.47138302 |
| 50 | MP0008775_abnormal_heart_ventricle | 1.45847727 |
| 51 | MP0004036_abnormal_muscle_relaxation | 1.41780924 |
| 52 | MP0003941_abnormal_skin_development | 1.41176773 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.40934994 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.40552035 |
| 55 | MP0003121_genomic_imprinting | 1.38371598 |
| 56 | MP0000762_abnormal_tongue_morphology | 1.37924418 |
| 57 | MP0001661_extended_life_span | 1.37248977 |
| 58 | MP0005083_abnormal_biliary_tract | 1.35801605 |
| 59 | MP0005508_abnormal_skeleton_morphology | 1.32870523 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.32020343 |
| 61 | MP0009384_cardiac_valve_regurgitation | 1.27337733 |
| 62 | MP0005365_abnormal_bile_salt | 1.25601721 |
| 63 | MP0002098_abnormal_vibrissa_morphology | 1.24081421 |
| 64 | MP0003879_abnormal_hair_cell | 1.22926933 |
| 65 | MP0000428_abnormal_craniofacial_morphol | 1.21010184 |
| 66 | MP0002108_abnormal_muscle_morphology | 1.20655809 |
| 67 | MP0000467_abnormal_esophagus_morphology | 1.20124733 |
| 68 | MP0005257_abnormal_intraocular_pressure | 1.19601849 |
| 69 | MP0002896_abnormal_bone_mineralization | 1.18810728 |
| 70 | MP0000566_synostosis | 1.16488648 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.15727415 |
| 72 | MP0010329_abnormal_lipoprotein_level | 1.14970996 |
| 73 | MP0000537_abnormal_urethra_morphology | 1.14788840 |
| 74 | MP0002089_abnormal_postnatal_growth/wei | 1.14468228 |
| 75 | MP0001177_atelectasis | 1.13930772 |
| 76 | MP0003279_aneurysm | 1.13619813 |
| 77 | MP0003115_abnormal_respiratory_system | 1.11833784 |
| 78 | MP0004858_abnormal_nervous_system | 1.09642300 |
| 79 | MP0001944_abnormal_pancreas_morphology | 1.09055261 |
| 80 | MP0002249_abnormal_larynx_morphology | 1.07237193 |
| 81 | MP0000049_abnormal_middle_ear | 1.06797706 |
| 82 | MP0002295_abnormal_pulmonary_circulatio | 1.06563065 |
| 83 | MP0009053_abnormal_anal_canal | 1.05935306 |
| 84 | MP0000230_abnormal_systemic_arterial | 1.05706402 |
| 85 | MP0006138_congestive_heart_failure | 1.03493071 |
| 86 | MP0005408_hypopigmentation | 1.03444718 |
| 87 | MP0002128_abnormal_blood_circulation | 1.02380904 |
| 88 | MP0002115_abnormal_skeleton_extremities | 1.01518147 |
| 89 | MP0001756_abnormal_urination | 0.97311323 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.96047518 |
| 91 | MP0001915_intracranial_hemorrhage | 0.95643814 |
| 92 | MP0003935_abnormal_craniofacial_develop | 0.94620955 |
| 93 | MP0005379_endocrine/exocrine_gland_phen | 0.94442541 |
| 94 | MP0010771_integument_phenotype | 0.93633737 |
| 95 | MP0003091_abnormal_cell_migration | 0.93586318 |
| 96 | MP0000767_abnormal_smooth_muscle | 0.93061987 |
| 97 | MP0004130_abnormal_muscle_cell | 0.92670135 |
| 98 | MP0001346_abnormal_lacrimal_gland | 0.91964338 |
| 99 | MP0002233_abnormal_nose_morphology | 0.91812849 |
| 100 | MP0005023_abnormal_wound_healing | 0.91092185 |
| 101 | MP0005623_abnormal_meninges_morphology | 0.90497608 |
| 102 | MP0003638_abnormal_response/metabolism_ | 0.90399491 |
| 103 | MP0001851_eye_inflammation | 0.90347456 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.90278766 |
| 105 | MP0000516_abnormal_urinary_system | 0.89060563 |
| 106 | MP0005367_renal/urinary_system_phenotyp | 0.89060563 |
| 107 | MP0003890_abnormal_embryonic-extraembry | 0.86828221 |
| 108 | MP0001849_ear_inflammation | 0.86253970 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.86200466 |
| 110 | MP0005165_increased_susceptibility_to | 0.85256475 |
| 111 | MP0001765_abnormal_ion_homeostasis | 0.85154111 |
| 112 | MP0002116_abnormal_craniofacial_bone | 0.83956770 |
| 113 | MP0005388_respiratory_system_phenotype | 0.83650790 |
| 114 | MP0002133_abnormal_respiratory_system | 0.83650790 |
| 115 | MP0003755_abnormal_palate_morphology | 0.83315828 |
| 116 | MP0005394_taste/olfaction_phenotype | 0.83225508 |
| 117 | MP0005499_abnormal_olfactory_system | 0.83225508 |
| 118 | MP0003787_abnormal_imprinting | 0.82776845 |
| 119 | MP0003385_abnormal_body_wall | 0.82382401 |
| 120 | MP0010630_abnormal_cardiac_muscle | 0.82239680 |
| 121 | MP0002109_abnormal_limb_morphology | 0.82007214 |
| 122 | MP0001666_abnormal_nutrient_absorption | 0.81848850 |
| 123 | MP0000377_abnormal_hair_follicle | 0.81633204 |
| 124 | MP0003300_gastrointestinal_ulcer | 0.80857446 |
| 125 | MP0005085_abnormal_gallbladder_physiolo | 0.80650064 |
| 126 | MP0001664_abnormal_digestion | 0.80484160 |
| 127 | MP0000383_abnormal_hair_follicle | 0.80076323 |
| 128 | MP0002972_abnormal_cardiac_muscle | 0.78976711 |
| 129 | MP0009697_abnormal_copulation | 0.78792205 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.78152405 |
| 131 | MP0003045_fibrosis | 0.78143748 |
| 132 | MP0003718_maternal_effect | 0.77600009 |
| 133 | MP0001544_abnormal_cardiovascular_syste | 0.77244841 |
| 134 | MP0005385_cardiovascular_system_phenoty | 0.77244841 |
| 135 | MP0002925_abnormal_cardiovascular_devel | 0.77099522 |
| 136 | MP0010678_abnormal_skin_adnexa | 0.77006870 |
| 137 | MP0002234_abnormal_pharynx_morphology | 0.76782799 |
| 138 | MP0004233_abnormal_muscle_weight | 0.75687090 |
| 139 | MP0005220_abnormal_exocrine_pancreas | 0.75683758 |
| 140 | MP0002932_abnormal_joint_morphology | 0.75503407 |
| 141 | MP0001299_abnormal_eye_distance/ | 0.75162527 |
| 142 | MP0005164_abnormal_response_to | 0.74440520 |
| 143 | MP0009115_abnormal_fat_cell | 0.73087668 |
| 144 | MP0005620_abnormal_muscle_contractility | 0.72676017 |
| 145 | MP0002086_abnormal_extraembryonic_tissu | 0.71922206 |
| 146 | MP0002876_abnormal_thyroid_physiology | 0.71836696 |
| 147 | MP0000432_abnormal_head_morphology | 0.71189272 |
| 148 | MP0003828_pulmonary_edema | 0.71108942 |
| 149 | MP0001614_abnormal_blood_vessel | 0.69999843 |
| 150 | MP0004883_abnormal_blood_vessel | 0.69790167 |
| 151 | MP0004087_abnormal_muscle_fiber | 0.69325360 |
| 152 | MP0000462_abnormal_digestive_system | 0.64443805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Menorrhagia (HP:0000132) | 7.10781258 |
| 2 | Increased mean platelet volume (HP:0011877) | 6.76948485 |
| 3 | Abnormal platelet volume (HP:0011876) | 5.92581501 |
| 4 | Prolonged bleeding time (HP:0003010) | 5.90441073 |
| 5 | Purpura (HP:0000979) | 5.06575632 |
| 6 | Hepatoblastoma (HP:0002884) | 4.27943969 |
| 7 | Petechiae (HP:0000967) | 4.16389823 |
| 8 | Gingival bleeding (HP:0000225) | 3.84633549 |
| 9 | Hyperactive renin-angiotensin system (HP:0000841) | 3.70108835 |
| 10 | Epistaxis (HP:0000421) | 3.54679222 |
| 11 | Impaired platelet aggregation (HP:0003540) | 3.29695827 |
| 12 | Abnormal platelet function (HP:0011869) | 3.29695827 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 3.20222921 |
| 14 | Broad metatarsal (HP:0001783) | 2.98444949 |
| 15 | Deep venous thrombosis (HP:0002625) | 2.90239960 |
| 16 | Bilateral microphthalmos (HP:0007633) | 2.87444085 |
| 17 | Acanthocytosis (HP:0001927) | 2.82539543 |
| 18 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.81568258 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 2.76009224 |
| 20 | Abnormality of chloride homeostasis (HP:0011422) | 2.71604725 |
| 21 | Abnormal pancreas size (HP:0012094) | 2.70020055 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 2.64404355 |
| 23 | Cervical subluxation (HP:0003308) | 2.58768155 |
| 24 | Abnormality of carpal bone ossification (HP:0006257) | 2.53384719 |
| 25 | Flat acetabular roof (HP:0003180) | 2.51978577 |
| 26 | Flat capital femoral epiphysis (HP:0003370) | 2.51451727 |
| 27 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.49091362 |
| 28 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.47149354 |
| 29 | Cardiovascular calcification (HP:0011915) | 2.41809268 |
| 30 | Vascular calcification (HP:0004934) | 2.41093572 |
| 31 | Hyperkalemia (HP:0002153) | 2.40416921 |
| 32 | Xanthomatosis (HP:0000991) | 2.39657930 |
| 33 | Abnormality of renin-angiotensin system (HP:0000847) | 2.30424127 |
| 34 | Partial duplication of thumb phalanx (HP:0009944) | 2.28932976 |
| 35 | Joint hemorrhage (HP:0005261) | 2.28694654 |
| 36 | Acanthosis nigricans (HP:0000956) | 2.27460426 |
| 37 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.26303442 |
| 38 | Nasolacrimal duct obstruction (HP:0000579) | 2.25476885 |
| 39 | Fragile skin (HP:0001030) | 2.24842977 |
| 40 | Poikilocytosis (HP:0004447) | 2.20623372 |
| 41 | Lymphangioma (HP:0100764) | 2.18391724 |
| 42 | Hypoplastic labia majora (HP:0000059) | 2.17304561 |
| 43 | Hypokalemia (HP:0002900) | 2.16950503 |
| 44 | Metaphyseal cupping (HP:0003021) | 2.16718200 |
| 45 | Abnormality of potassium homeostasis (HP:0011042) | 2.16364589 |
| 46 | Pterygium (HP:0001059) | 2.15838919 |
| 47 | Partial duplication of the phalanx of hand (HP:0009999) | 2.15796948 |
| 48 | Thin bony cortex (HP:0002753) | 2.15586969 |
| 49 | Mitral stenosis (HP:0001718) | 2.15571053 |
| 50 | Hyperaldosteronism (HP:0000859) | 2.13582791 |
| 51 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.12188513 |
| 52 | Hypokalemic alkalosis (HP:0001949) | 2.09488367 |
| 53 | Decreased circulating renin level (HP:0003351) | 2.08702336 |
| 54 | Bundle branch block (HP:0011710) | 2.07805210 |
| 55 | Bronchomalacia (HP:0002780) | 2.07197988 |
| 56 | Protrusio acetabuli (HP:0003179) | 2.06621377 |
| 57 | Premature rupture of membranes (HP:0001788) | 2.05946370 |
| 58 | Bifid tongue (HP:0010297) | 2.05893855 |
| 59 | Bruising susceptibility (HP:0000978) | 2.05669406 |
| 60 | Shallow orbits (HP:0000586) | 2.04713569 |
| 61 | Abnormality of the lacrimal duct (HP:0011481) | 2.03931535 |
| 62 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.03799004 |
| 63 | Abnormality of the acetabulum (HP:0003170) | 2.03740725 |
| 64 | Generalized aminoaciduria (HP:0002909) | 2.03726486 |
| 65 | Abnormal ossification of hand bones (HP:0005921) | 2.03277653 |
| 66 | Abnormality of the Achilles tendon (HP:0005109) | 2.02148050 |
| 67 | Arterial tortuosity (HP:0005116) | 2.01123338 |
| 68 | Advanced eruption of teeth (HP:0006288) | 2.00616952 |
| 69 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.00496942 |
| 70 | Abnormal auditory evoked potentials (HP:0006958) | 2.00441296 |
| 71 | Ankle contracture (HP:0006466) | 2.00419662 |
| 72 | Aortic aneurysm (HP:0004942) | 2.00117049 |
| 73 | Neonatal death (HP:0003811) | 1.99171991 |
| 74 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.98996848 |
| 75 | Aplasia of the phalanges of the hand (HP:0009802) | 1.98996848 |
| 76 | Aplasia involving bones of the extremities (HP:0009825) | 1.98996848 |
| 77 | Spinal rigidity (HP:0003306) | 1.98637506 |
| 78 | Mesangial abnormality (HP:0001966) | 1.98413608 |
| 79 | Renal salt wasting (HP:0000127) | 1.96833921 |
| 80 | Papillary thyroid carcinoma (HP:0002895) | 1.95682319 |
| 81 | Shawl scrotum (HP:0000049) | 1.94809500 |
| 82 | Increased connective tissue (HP:0009025) | 1.94500223 |
| 83 | Focal segmental glomerulosclerosis (HP:0000097) | 1.94361526 |
| 84 | Hypercholesterolemia (HP:0003124) | 1.93995090 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 1.93074066 |
| 86 | Bone cyst (HP:0012062) | 1.91816563 |
| 87 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.90942042 |
| 88 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.90098813 |
| 89 | Conjunctival telangiectasia (HP:0000524) | 1.89978202 |
| 90 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.89965667 |
| 91 | Hypophosphatemic rickets (HP:0004912) | 1.89741342 |
| 92 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.88685429 |
| 93 | Abnormal delivery (HP:0001787) | 1.88636586 |
| 94 | Visceral angiomatosis (HP:0100761) | 1.86686516 |
| 95 | Embryonal renal neoplasm (HP:0011794) | 1.86508659 |
| 96 | Macroorchidism (HP:0000053) | 1.86419996 |
| 97 | Growth hormone excess (HP:0000845) | 1.86378275 |
| 98 | Mesomelia (HP:0003027) | 1.86161126 |
| 99 | Delayed epiphyseal ossification (HP:0002663) | 1.85799691 |
| 100 | Asymmetry of the thorax (HP:0001555) | 1.85000553 |
| 101 | Atrophic scars (HP:0001075) | 1.84591491 |
| 102 | Epiphyseal dysplasia (HP:0002656) | 1.83564186 |
| 103 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.83342933 |
| 104 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.83342933 |
| 105 | Abnormality of the labia majora (HP:0012881) | 1.83059189 |
| 106 | Abnormality of the nasolacrimal system (HP:0000614) | 1.82487810 |
| 107 | Accelerated skeletal maturation (HP:0005616) | 1.82151308 |
| 108 | Ankyloglossia (HP:0010296) | 1.81538825 |
| 109 | Abnormal cartilage morphology (HP:0002763) | 1.80691263 |
| 110 | Glomerulosclerosis (HP:0000096) | 1.80234798 |
| 111 | Back pain (HP:0003418) | 1.79134955 |
| 112 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.78604208 |
| 113 | Enlarged epiphyses (HP:0010580) | 1.77987309 |
| 114 | Hemangiomatosis (HP:0007461) | 1.77551023 |
| 115 | Turricephaly (HP:0000262) | 1.77201698 |
| 116 | Pili torti (HP:0003777) | 1.76635336 |
| 117 | Complement deficiency (HP:0004431) | 1.75651753 |
| 118 | Neonatal short-limb short stature (HP:0008921) | 1.75012364 |
| 119 | Germ cell neoplasia (HP:0100728) | 1.74657179 |
| 120 | Dyschromatopsia (HP:0007641) | 1.74590820 |
| 121 | Gout (HP:0001997) | 1.74563889 |
| 122 | Distal lower limb muscle weakness (HP:0009053) | 1.74015077 |
| 123 | Abnormal pupillary function (HP:0007686) | 1.73783919 |
| 124 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73691551 |
| 125 | Fragile nails (HP:0001808) | 1.73493782 |
| 126 | Renal duplication (HP:0000075) | 1.73239381 |
| 127 | Buphthalmos (HP:0000557) | 1.72978777 |
| 128 | Vascular tortuosity (HP:0004948) | 1.72881251 |
| 129 | Metabolic alkalosis (HP:0200114) | 1.72470767 |
| 130 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.72251378 |
| 131 | Popliteal pterygium (HP:0009756) | 1.71856654 |
| 132 | Oligomenorrhea (HP:0000876) | 1.70670810 |
| 133 | Skin pits (HP:0100276) | 1.69207680 |
| 134 | Aneurysm (HP:0002617) | 1.68926270 |
| 135 | Renal tubular acidosis (HP:0001947) | 1.68410226 |
| 136 | Spontaneous abortion (HP:0005268) | 1.67928961 |
| 137 | Exostoses (HP:0100777) | 1.67884827 |
| 138 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.67809172 |
| 139 | Broad palm (HP:0001169) | 1.67335590 |
| 140 | Coxa vara (HP:0002812) | 1.67148034 |
| 141 | Abnormal hand bone ossification (HP:0010660) | 1.66995105 |
| 142 | Broad thumb (HP:0011304) | 1.66633167 |
| 143 | Preaxial foot polydactyly (HP:0001841) | 1.65730309 |
| 144 | Type 1 muscle fiber predominance (HP:0003803) | 1.65706760 |
| 145 | Abnormality of complement system (HP:0005339) | 1.65676584 |
| 146 | Hyperglycemia (HP:0003074) | 1.65111401 |
| 147 | Broad face (HP:0000283) | 1.65003067 |
| 148 | Cerebral aneurysm (HP:0004944) | 1.63791002 |
| 149 | Ventricular tachycardia (HP:0004756) | 1.63632426 |
| 150 | Neoplasm of the heart (HP:0100544) | 1.63571300 |
| 151 | Osteoarthritis (HP:0002758) | 1.63508859 |
| 152 | Abnormality of the frontal sinuses (HP:0002687) | 1.63493565 |
| 153 | Rickets (HP:0002748) | 1.63222776 |
| 154 | Osteolytic defects of the hand bones (HP:0009699) | 1.63100558 |
| 155 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.63100558 |
| 156 | Laryngomalacia (HP:0001601) | 1.63000301 |
| 157 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.62843419 |
| 158 | Uterine leiomyosarcoma (HP:0002891) | 1.62581091 |
| 159 | Leiomyosarcoma (HP:0100243) | 1.62581091 |
| 160 | Preauricular pit (HP:0004467) | 1.62094907 |
| 161 | Periauricular skin pits (HP:0100277) | 1.62094907 |
| 162 | Increased variability in muscle fiber diameter (HP:0003557) | 1.61975217 |
| 163 | Abnormality of the intrinsic pathway (HP:0010989) | 1.61728312 |
| 164 | Milia (HP:0001056) | 1.59767384 |
| 165 | Aortic dissection (HP:0002647) | 1.59481402 |
| 166 | Abnormal tarsal ossification (HP:0008369) | 1.58692964 |
| 167 | Exercise-induced myalgia (HP:0003738) | 1.57119001 |
| 168 | Hemorrhage of the eye (HP:0011885) | 1.56509620 |
| 169 | Conjugated hyperbilirubinemia (HP:0002908) | 1.56506169 |
| 170 | Myocardial infarction (HP:0001658) | 1.54219676 |
| 171 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.54062612 |
| 172 | Bladder diverticulum (HP:0000015) | 1.53549483 |
| 173 | Wormian bones (HP:0002645) | 1.52413231 |
| 174 | Alopecia of scalp (HP:0002293) | 1.52000798 |
| 175 | Prolonged partial thromboplastin time (HP:0003645) | 1.51917969 |
| 176 | Hyperthyroidism (HP:0000836) | 1.51414298 |
| 177 | Intrahepatic cholestasis (HP:0001406) | 1.50871564 |
| 178 | Upper limb muscle weakness (HP:0003484) | 1.50298954 |
| 179 | Thin skin (HP:0000963) | 1.50052717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.89394191 |
| 2 | ERN1 | 3.69543041 |
| 3 | EIF2AK1 | 2.99567870 |
| 4 | EPHA2 | 2.73217187 |
| 5 | MAP3K2 | 2.70280362 |
| 6 | TGFBR2 | 2.64889110 |
| 7 | LATS1 | 2.56510855 |
| 8 | PRKD3 | 2.55164462 |
| 9 | RIPK1 | 2.36360452 |
| 10 | TRIB3 | 2.34715004 |
| 11 | FGFR2 | 2.30794025 |
| 12 | WNK4 | 2.25701863 |
| 13 | CDK12 | 2.25653911 |
| 14 | STK24 | 2.17344650 |
| 15 | INSRR | 2.08248788 |
| 16 | GRK5 | 2.01988913 |
| 17 | EEF2K | 1.99341328 |
| 18 | CAMK1D | 1.99283949 |
| 19 | TIE1 | 1.91410455 |
| 20 | AKT3 | 1.87393947 |
| 21 | ARAF | 1.83211427 |
| 22 | MST4 | 1.81386507 |
| 23 | MAPKAPK3 | 1.75772459 |
| 24 | PDGFRA | 1.70139543 |
| 25 | HIPK2 | 1.68490555 |
| 26 | EPHB2 | 1.66796836 |
| 27 | MAP3K3 | 1.65540224 |
| 28 | WNK1 | 1.61754468 |
| 29 | LMTK2 | 1.58485313 |
| 30 | SIK1 | 1.47787755 |
| 31 | CAMK1G | 1.46976909 |
| 32 | FGFR4 | 1.45939812 |
| 33 | FGFR3 | 1.43481778 |
| 34 | FER | 1.41360985 |
| 35 | TTN | 1.41348209 |
| 36 | PRKG2 | 1.40537747 |
| 37 | GRK1 | 1.39221564 |
| 38 | PAK4 | 1.37510673 |
| 39 | DDR2 | 1.35490439 |
| 40 | STK38L | 1.35479296 |
| 41 | WNK3 | 1.32103286 |
| 42 | MST1R | 1.31091171 |
| 43 | MYLK | 1.29911192 |
| 44 | PASK | 1.25691880 |
| 45 | PAK2 | 1.22982937 |
| 46 | MAPK7 | 1.18451525 |
| 47 | MAP3K6 | 1.14090192 |
| 48 | PTK2 | 1.14014249 |
| 49 | PIM2 | 1.13392676 |
| 50 | CAMK4 | 1.12717712 |
| 51 | MAPK15 | 1.07706658 |
| 52 | PAK3 | 1.05722821 |
| 53 | MARK2 | 1.05079837 |
| 54 | MAP2K2 | 1.04684662 |
| 55 | PTK6 | 1.03996316 |
| 56 | MAP3K7 | 1.02597492 |
| 57 | ICK | 1.00419595 |
| 58 | STK3 | 1.00214543 |
| 59 | TRPM7 | 0.99436348 |
| 60 | OXSR1 | 0.98470341 |
| 61 | ADRBK2 | 0.96513036 |
| 62 | MAP3K1 | 0.94723560 |
| 63 | PKN2 | 0.94642192 |
| 64 | NTRK1 | 0.92252840 |
| 65 | SGK2 | 0.88419722 |
| 66 | MET | 0.85634756 |
| 67 | TGFBR1 | 0.84725629 |
| 68 | RPS6KA2 | 0.82840827 |
| 69 | PHKG2 | 0.79550647 |
| 70 | PHKG1 | 0.79550647 |
| 71 | PRKCH | 0.77556232 |
| 72 | PRKD2 | 0.72957031 |
| 73 | ABL2 | 0.72003736 |
| 74 | IRAK3 | 0.71858082 |
| 75 | PDGFRB | 0.71138201 |
| 76 | SGK223 | 0.70575625 |
| 77 | SGK494 | 0.70575625 |
| 78 | ADRBK1 | 0.70135363 |
| 79 | DAPK3 | 0.67012728 |
| 80 | CDK6 | 0.66769545 |
| 81 | ERBB2 | 0.66682863 |
| 82 | SMG1 | 0.66603217 |
| 83 | PBK | 0.65131123 |
| 84 | TEC | 0.64980857 |
| 85 | EPHA3 | 0.64772247 |
| 86 | DMPK | 0.63601842 |
| 87 | SGK3 | 0.62847711 |
| 88 | MAP2K1 | 0.62022174 |
| 89 | ILK | 0.61632524 |
| 90 | BRSK2 | 0.61495631 |
| 91 | NEK9 | 0.58961213 |
| 92 | LATS2 | 0.58809895 |
| 93 | CDK9 | 0.58210659 |
| 94 | CSF1R | 0.58133540 |
| 95 | IGF1R | 0.57691555 |
| 96 | CDC42BPA | 0.56775161 |
| 97 | TYRO3 | 0.53819369 |
| 98 | PAK1 | 0.52314846 |
| 99 | CDK8 | 0.52162922 |
| 100 | FGFR1 | 0.52124565 |
| 101 | NTRK3 | 0.51971482 |
| 102 | RPS6KB2 | 0.51440340 |
| 103 | PIK3CA | 0.51395644 |
| 104 | TESK1 | 0.50704687 |
| 105 | BRAF | 0.50463699 |
| 106 | BMX | 0.49811316 |
| 107 | NUAK1 | 0.49806106 |
| 108 | GRK6 | 0.48935246 |
| 109 | MTOR | 0.48397351 |
| 110 | GSK3A | 0.46909622 |
| 111 | STK38 | 0.46871145 |
| 112 | PRKAA2 | 0.45632894 |
| 113 | PRKCE | 0.45368250 |
| 114 | PRKD1 | 0.45167785 |
| 115 | CAMK1 | 0.45142352 |
| 116 | ZAP70 | 0.44751521 |
| 117 | MATK | 0.43911957 |
| 118 | PIK3CG | 0.43562765 |
| 119 | OBSCN | 0.42664926 |
| 120 | PRPF4B | 0.41934930 |
| 121 | EPHA4 | 0.41599012 |
| 122 | BCKDK | 0.41208081 |
| 123 | RET | 0.40219339 |
| 124 | TAOK1 | 0.40212351 |
| 125 | MUSK | 0.39986304 |
| 126 | STK4 | 0.39069038 |
| 127 | CSNK1E | 0.38906677 |
| 128 | CAMK2G | 0.38348107 |
| 129 | PTK2B | 0.37936666 |
| 130 | ROCK1 | 0.36658686 |
| 131 | PNCK | 0.36585141 |
| 132 | MOS | 0.36465005 |
| 133 | STK39 | 0.36417165 |
| 134 | DYRK1B | 0.36310012 |
| 135 | NEK2 | 0.35774470 |
| 136 | PRKCI | 0.35731200 |
| 137 | CDK3 | 0.34147835 |
| 138 | KSR2 | 0.33860795 |
| 139 | CASK | 0.33693921 |
| 140 | PDPK1 | 0.33387685 |
| 141 | TAOK3 | 0.32771911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.94998139 |
| 2 | Platelet activation_Homo sapiens_hsa04611 | 2.52417562 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.23038665 |
| 4 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.21727868 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.17598529 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.16658542 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92838345 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.87224285 |
| 9 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.78653628 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.68744184 |
| 11 | Focal adhesion_Homo sapiens_hsa04510 | 1.59107293 |
| 12 | Renin secretion_Homo sapiens_hsa04924 | 1.47190503 |
| 13 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.46547460 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.45460186 |
| 15 | Protein export_Homo sapiens_hsa03060 | 1.45328431 |
| 16 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.45320916 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.44097292 |
| 18 | Thyroid cancer_Homo sapiens_hsa05216 | 1.39030159 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.38047498 |
| 20 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.37946181 |
| 21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.35609636 |
| 22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.34418725 |
| 23 | Gap junction_Homo sapiens_hsa04540 | 1.31186522 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.30881513 |
| 25 | Adherens junction_Homo sapiens_hsa04520 | 1.29717233 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29435714 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26796591 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.25638972 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22137888 |
| 30 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.20655940 |
| 31 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.18392646 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18075190 |
| 33 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.17947933 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.16985968 |
| 35 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.14351460 |
| 36 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.12788950 |
| 37 | Insulin resistance_Homo sapiens_hsa04931 | 1.11885231 |
| 38 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.09192823 |
| 39 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.08730230 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.07994746 |
| 41 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.07166501 |
| 42 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.06804848 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05293086 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.05168448 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04614365 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03676550 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02592809 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02363166 |
| 49 | Prostate cancer_Homo sapiens_hsa05215 | 1.02191201 |
| 50 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.01593332 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.01420431 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00813869 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96660090 |
| 54 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.95583875 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94990016 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94308921 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.94217984 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.94114753 |
| 59 | Melanogenesis_Homo sapiens_hsa04916 | 0.93958858 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93401700 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93018905 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92641888 |
| 63 | Melanoma_Homo sapiens_hsa05218 | 0.90898260 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.90060049 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89903797 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89844525 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.89160632 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.88346974 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88286494 |
| 70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.87923493 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87673880 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87452085 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87134479 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85782496 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85758605 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.84910535 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84383338 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83800904 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.83564522 |
| 80 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83077240 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82931929 |
| 82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82657369 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.81798094 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81164330 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80714457 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.80041350 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79794496 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78814923 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78723646 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78576664 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77965978 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77939650 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74735008 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74031539 |
| 95 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.73886645 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73774416 |
| 97 | Pathways in cancer_Homo sapiens_hsa05200 | 0.73754130 |
| 98 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73574262 |
| 99 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.73394393 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.72851323 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72791554 |
| 102 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72533065 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71727643 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.70792613 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70075721 |
| 106 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69027008 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68456872 |
| 108 | Lysosome_Homo sapiens_hsa04142 | 0.68242360 |
| 109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67538305 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66742508 |
| 111 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.65882686 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65720830 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65035206 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.64765596 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64615119 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64345291 |
| 117 | Long-term potentiation_Homo sapiens_hsa04720 | 0.62902187 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62071300 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61771629 |
| 120 | Long-term depression_Homo sapiens_hsa04730 | 0.61704406 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61596185 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61333478 |
| 123 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61149901 |
| 124 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60951665 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60738057 |
| 126 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60611772 |
| 127 | Salivary secretion_Homo sapiens_hsa04970 | 0.58974263 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58888043 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58313421 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57524717 |
| 131 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57474983 |
| 132 | Taste transduction_Homo sapiens_hsa04742 | 0.57204874 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56940966 |
| 134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56101066 |
| 135 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55645818 |
| 136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54386216 |
| 137 | ABC transporters_Homo sapiens_hsa02010 | 0.53519645 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52779728 |
| 139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51877526 |
| 140 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.50976541 |
| 141 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44698713 |

